Godrej Agrovet Limited announced the launch of TAKAI, a new insecticide specifically developed for rice crops on February 7, 2026. The product launch was disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Product Overview and Technology

TAKAI is powered by Cyclapryn technology developed by ISK Japan and is designed to combat key rice pests, particularly Stem Borer and Leaf Folder. The insecticide provides comprehensive protection when applied at specific growth stages of the rice crop.

Application Protocol and Effectiveness

TAKAI follows a strategic two-stage application protocol designed to maximize crop protection during critical growth periods. The insecticide should be applied at a dose of 160 ml during 15-30 Days After Transplant (DAT) and again at 40-60 DAT, providing an extensive protection window for the rice crop.

The timing addresses specific pest behavior patterns. During the early vegetative stage (15-30 DAT), Stem Borer damages plants in ways that are difficult for farmers to detect early. Later, during the reproductive stage (40-60 DAT), both Stem Borer and Leaf Folder attack the plant, with Leaf Folder feeding on leaf tissue by folding leaves, thereby reducing the plant's photosynthetic area and crop growth.

Market Impact and Expansion Plans

The company is currently in the process of obtaining label approval for TAKAI in additional crops including Maize, Chilli, Cabbage, Soybean, Chickpea and Sugarcane. This expansion would significantly broaden the product's market reach beyond rice cultivation.

Industry Context and Farmer Requirements

According to N.K. Rajavelu, CEO – Crop Protection Business, Godrej Agrovet, the company's pre-launch rice farmer survey revealed that 77% of farmers value quick pest control, long-lasting effects, and improved crop health. TAKAI addresses these requirements through rapid feeding cessation and sustained pest control over extended periods.

The launch comes at a critical time for Indian agriculture, as rice is grown as a multi-season crop – Kharif, Rabi and Summer – in warm, humid and waterlogged conditions that make crops ideal targets for pest attacks throughout the year. While India is the world's largest producer of rice with production of 150.18 million tonnes, its per-hectare yield remains significantly low at approximately 2.90 tonnes/hectare compared to the global best of 5.00 tonnes/hectare.

Strategic Partnership and Market Position

The collaboration with ISK Japan for Cyclapryn technology represents Godrej Agrovet's strategy of leveraging international research expertise to strengthen its portfolio across key crops. Sunil Kataria, MD & CEO, Godrej Agrovet, emphasized that effective pest management determines the success of Indian rice farmers, and TAKAI enables farmers to protect their crops while improving overall crop health through solutions that offer quick control and longer-duration effectiveness.

The Board of Directors of Godrej Agrovet Limited approved the investor presentation for Q3FY26 results at their meeting held on February 3, 2026. The company announced its unaudited financial results for Q3FY26 ended December 31, 2025, delivering exceptional performance with revenue growth of 11% and strong profitability improvements. The company reported consolidated net profit of ₹110 crore and revenue from operations of ₹2,718 crore, demonstrating robust operational execution across key business segments.

Board Meeting and Regulatory Compliance

The Board meeting held on February 3, 2026, approved both standalone and consolidated unaudited financial results for the quarter and nine months period ended December 31, 2025. The investor presentation has been placed on the company's website at www.godrejagrovet.com and communicated to BSE Limited and National Stock Exchange of India Limited pursuant to Regulations 30, 33 and 52(4) of SEBI Listing Regulations.

Financial Performance Overview

The company's Q3FY26 consolidated performance showcases strong double-digit revenue growth with enhanced profitability metrics. EBITDA improved to ₹260 crore from ₹229 crore in the corresponding quarter last year, with EBITDA margin expanding to 9.6% from 9.3% year-on-year. Profit before tax registered impressive growth of 23.1% to ₹169 crore, reflecting sustained margin expansion and operational efficiencies.

Segment-wise Business Performance

The company's diversified business model demonstrated strong performance across multiple segments. Animal Feed business achieved robust volume growth driven by 21% year-on-year growth in cattle feed, while Vegetable Oil segment registered healthy 27% revenue growth supported by 16% improvement in Fresh Fruit Bunch arrivals and enhanced Oil Extraction Ratio.

Nine Months Performance

For the nine months ended December 31, 2025, the company achieved consolidated revenue from operations of ₹7,900 crore compared to ₹7,249 crore in the corresponding period last year, representing 9.0% growth. Net profit for the nine-month period stood at ₹343 crore versus ₹337 crore in the previous year, with EBITDA margin maintained at 9.7%.

Management Commentary and Outlook

Commenting on the performance, Managing Director Sunil Kataria highlighted Q3FY26 as an exceptional quarter with robust double-digit revenue growth and strong profitability improvement. The performance was driven by sustained margin expansion across key businesses, supported by sharp operational execution and continued focus on value creation. All key businesses, particularly Vegetable Oil, Animal Feed and Poultry, delivered solid improvements with enhanced operational parameters and strategic initiatives yielding positive results.